Cadwalader Takes Corporate Inversions to Another Level

, The Am Law Daily

   | 0 Comments

Cadwalader, Wickersham & Taft may have found a way to help more U.S. companies use corporate inversions to lower their tax bills. Salix Pharmaceuticals has retained the firm, as well as Covington & Burling and leading Irish shop A&L Goodbody, for its $2.7 billion acquisition of patents to gastrointestinal drugs owned by an Irish unit of Italy's Cosmo Pharmaceuticals.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202662691305

Thank you!

This article's comments will be reviewed.